Compare OPK & GDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OPK | GDRX |
|---|---|---|
| Founded | 2006 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 921.2M | 868.9M |
| IPO Year | 2011 | 2020 |
| Metric | OPK | GDRX |
|---|---|---|
| Price | $1.21 | $2.09 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 10 |
| Target Price | $2.03 | ★ $4.36 |
| AVG Volume (30 Days) | 2.3M | ★ 4.0M |
| Earning Date | 05-29-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 125.00 |
| EPS | N/A | ★ 0.09 |
| Revenue | $606,879,000.00 | ★ $796,853,000.00 |
| Revenue This Year | N/A | $4.34 |
| Revenue Next Year | $8.75 | $7.05 |
| P/E Ratio | ★ N/A | $24.17 |
| Revenue Growth | N/A | ★ 0.57 |
| 52 Week Low | $1.11 | $1.77 |
| 52 Week High | $2.04 | $5.61 |
| Indicator | OPK | GDRX |
|---|---|---|
| Relative Strength Index (RSI) | 46.64 | 43.49 |
| Support Level | $1.12 | N/A |
| Resistance Level | $1.27 | $2.87 |
| Average True Range (ATR) | 0.04 | 0.17 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 60.71 | 45.87 |
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.